Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Valuable Targets
6 min read
Latest Developments in the Research and Development of CGAS Inhibitors
18 September 2023
CGAS (Cyclic GMP-AMP Synthase) is a crucial enzyme in the human body that plays a vital role in the innate immune response.
Drug Insights
4 min read
Pharmaceutical Insights: Zoledronic Acid's R&D Progress and its Mechanism of Action on Drug Target
18 September 2023
This article summarized the latest R&D progress of Zoledronic Acid, the Mechanism of Action for Zoledronic Acid, and the drug target R&D trends for Zoledronic Acid.
Latest Hotspot
4 min read
Lassen Therapeutics shares new data on LASN01's potential in treating Idiopathic Pulmonary Fibrosis and Thyroid Eye Disease
17 September 2023
Lassen Therapeutics is developing novel antibody treatments for fibro-inflammatory diseases and cancer, focusing on the IL-11R receptor (LASN01) and interleukin-18 binding proteins.
Drug Insights
4 min read
Exploring Zaleplon's Revolutionary R&D Successes
17 September 2023
This article summarized the latest R&D progress of Zaleplon, the Mechanism of Action for Zaleplon, and the drug target R&D trends for Zaleplon.
Valuable Targets
5 min read
Cystic Fibrosis Treatment Drug - CFTR Modulators
17 September 2023
The CFTR protein is an ion channel mainly used to regulate the transepithelial movement of anions in mucus secretion tissues, thereby coordinating the balance of salt and fluid levels in mucus secretions.
Drug Insights
4 min read
Decoding Venetoclax: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
17 September 2023
This article summarized the latest R&D progress of Venetoclax, the Mechanism of Action for Venetoclax, and the drug target R&D trends for Venetoclax.
Latest Hotspot
4 min read
The primary endpoint achieved by FASENRA in the Phase III MANDARA trial for eosinophilic granulomatosis with polyangiitis
17 September 2023
Positive high-level results from AstraZeneca's MANDARA Phase III study revealed that FASENRA(benralizumab)
Valuable Targets
5 min read
Nemesis of Hypercholesterolemia - CETP inhibitors
17 September 2023
CETP, or Cholesteryl Ester Transfer Protein, plays a crucial role in lipid metabolism within the human body.
Drug Insights
4 min read
Deep Scientific Insights on Triazolam's R&D Progress, Mechanism of Action, and Drug Target
17 September 2023
This article summarized the latest R&D progress of Triazolam, the Mechanism of Action for Triazolam, and the drug target R&D trends for Triazolam.
Latest Hotspot
3 min read
MBX Biosciences declares encouraging data from a Phase 1 Multiple Ascending Dose study for MBX 2109
17 September 2023
MBX Biosciences, Inc. released favorable outcomes from the Phase 1 trial's multiple ascending dose section for MBX 2109.
Drug Insights
4 min read
An In-depth Analysis of Tioconazole's R&D Progress and Mechanism of Action on Drug Target
17 September 2023
This article summarized the latest R&D progress of Tioconazole, the Mechanism of Action for Tioconazole, and the drug target R&D trends for Tioconazole.
Valuable Targets
6 min read
Star of transcriptional pathway potential: CDK9 inhibitor
17 September 2023
CDK9, also known as cyclin-dependent kinase 9, plays a crucial role in the regulation of gene expression and cell cycle progression in the human body.